DeepQure Reports Encouraging Clinical Data from World’s First Extravascular RDN System at AUA 2026
DeepQure presents clinical data of HyperQure™, the first minimally invasive extravascular renal denervation system, at the AUA Innovation Nexus Forum. The system aims to effectively treat uncontrolled hypertension by enabling comprehensive nerve ablation outside the artery framework, overcoming challenges posed by traditional methods. The company reported 15 completed cases across Korea and the US and is progressing toward a global pivotal trial.
WASHINGTON, May 14, 2026 /PRNewswire/ — DeepQure, a clinical-stage medical device company, announced the completion of its featured presentation at the American Urological Association (AUA) Innovation Nexus Forum, held during the AUA Annual Meeting. DeepQure was selected to present the…